ELV
US EQUITY
Health Care
Managed Health Care
CIK: 1156039
Elevance Health (ELV) Quant Factor Diagnostic & Fair Value Model
Elevance Health (Ticker: ELV) is listed in the Health Care sector (Managed Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$439.95
-1.20%
Latest Close (2026-10-23)
Market Cap: $454.18M
P/E Ratio: 16.4
Momentum Strength
3M / 12M
+16.28%
1M: +10.47%
12M: +27.44%
Quality (ROE)
Point-in-Time
+13.00%
Trailing Return on Equity
Technical Trend
RSI 14
80.2
SMA50: $408.05
SMA200: $371.14
Valuation Multiplier
Trailing
16.4
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
ELV trades within a typical sector multiple band (16.4x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1156039 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-07-15 | $50.47B | $1.46B | $6.25B | $6.71 |
| 10-Q | 2025-12-31 | 2026-07-15 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-07-15 | $49.78B | $1.74B | $3.07B | $7.72 |
| 10-Q | 2026-03-31 | 2026-04-22 | $50.18B | $1.76B | $4.33B | $8.00 |
| 10-Q | 2025-03-31 | 2026-04-22 | $48.89B | $2.18B | $1.02B | $9.61 |
| 10-K | 2025-12-31 | 2026-02-06 | $199.12B | $5.66B | $4.29B | $25.21 |
| 10-K | 2024-12-31 | 2026-02-06 | $177.01B | $5.98B | $5.81B | $25.68 |
| 10-K | 2023-12-31 | 2026-02-06 | $171.34B | $5.99B | $8.06B | $25.22 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Elevance Health (ELV) valuation multiples, momentum factors, and point-in-time filing conventions.
How should ELV's current valuation multiple be interpreted? ↓
ELV trades at a trailing P/E of 16.4x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are ELV's key momentum and technical factor indicators? ↓
As of the latest close, ELV shows a 1-month return of +10.47%, 3-month return of +16.28%, and 12-month return of +27.44%, with a 14-day RSI of 80.2. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for ELV? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can ELV be incorporated into systematic factor models? ↓
ELV can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.